Kirill Kirgizov, Physician in BMT department of the Russian Children’s Research Hospital of Pirogov Russian National Research Medical University, recently shared:
“I am very honored to inform that our LEAD study on behalf of EBMT was finally published in Nature BMT.
We analyzed the data from 579 patients with autoimmune diseases received autologous HSCT (disease outcomes and late effects).
This study was elected as the best oral presentation at EBMT 2025.”
Title: Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT)
Authors: Kirill Kirgizov, Raffaella Greco, Manuela Badoglio, Myriam Labopin, Riccardo Saccardi, Montserrat Rovira, Dominique Farge, Mieke W. H. Roeven, John Moore, Varun Mehra, Francesco Onida, Alexey Polushin, Jürgen Finke, Tobias Alexander, Joachim Burman, Nicoletta Del Papa, Diana M. Greenfield, Majid Kazmi, Alicia Rovo, Nina Salooja, Helene Schoemans, Basil Sharrack, Chiara Nozzoli, André Tichelli, Peter Bader, Selim Corbacioglu, Zinaida Peric, Elisa Roldan, Grzegorz W. Basak, John A. Snowden
Read the article.
Read also “Kirill Kirgizov: I Was Very Honored to Co-chair the Closing Ceremony of SIOP Asia 2026” on OncoDaily.
Kirill Kirgizov/Telegram